What is the treatment for Catheter-Related Bloodstream Infection (CRBSI) caused by Staphylococcus haemolyticus?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of CRBSI Caused by Staphylococcus haemolyticus

For catheter-related bloodstream infection (CRBSI) caused by Staphylococcus haemolyticus, initiate empirical vancomycin therapy and remove short-term catheters immediately; for long-term catheters, attempt salvage with systemic antibiotics plus antibiotic lock therapy for 10-14 days, but remove the catheter if fever or bacteremia persists beyond 72 hours. 1

Empirical Antibiotic Therapy

  • Start empirical therapy with vancomycin to cover coagulase-negative staphylococci (including S. haemolyticus), which are the most common pathogens in CRBSI 1
  • Add gram-negative coverage (third-generation cephalosporin, carbapenem, or β-lactam/β-lactamase combination) based on local antibiogram until culture results are available 1
  • Important caveat: S. haemolyticus can develop vancomycin resistance, particularly with prolonged vancomycin exposure, so monitor clinical response closely and obtain susceptibility testing 2
  • If vancomycin MIC is >1 mg/mL or clinical failure occurs, consider alternative agents such as daptomycin or linezolid 1

Catheter Management Strategy

For Short-Term (Non-Tunneled) Catheters:

  • Remove the catheter immediately and insert a new catheter at a different site 1
  • Treat with systemic antibiotics for 5-7 days after catheter removal if uncomplicated 3, 4

For Long-Term (Tunneled) Catheters or Ports:

  • Attempt catheter salvage if the patient has limited venous access, no tunnel/exit site infection, and no signs of severe sepsis 1
  • Use systemic antibiotics PLUS antibiotic lock therapy for 10-14 days 1, 3
  • Antibiotic lock should be instilled after each dialysis session (for hemodialysis catheters) or renewed every 24-48 hours for other long-term catheters 1
  • Remove the catheter if any of the following occur:
    • Persistent fever or bacteremia >72 hours despite appropriate antibiotics 1, 3
    • Clinical deterioration or hemodynamic instability 1
    • Evidence of metastatic infection (endocarditis, suppurative thrombophlebitis, osteomyelitis) 1, 3
    • Tunnel or exit site infection 1

Duration of Antibiotic Therapy

  • Uncomplicated CRBSI with catheter removal: 5-7 days of systemic antibiotics 3, 4
  • Uncomplicated CRBSI with catheter retention: 10-14 days of systemic antibiotics plus antibiotic lock therapy 1, 3
  • Persistent bacteremia >72 hours after catheter removal: Extend therapy to 4-6 weeks 1, 3
  • Complicated infections (endocarditis, suppurative thrombophlebitis, osteomyelitis): 4-6 weeks of parenteral therapy 1, 3

Antibiotic Lock Therapy Details

  • Combine the antibiotic (vancomycin or daptomycin) with heparin and instill into each catheter lumen 1, 5
  • Success rates for coagulase-negative staphylococci (including S. haemolyticus) with antibiotic lock therapy range from 75-85% 1, 5
  • Daptomycin lock therapy has demonstrated 85% cure rate for coagulase-negative staphylococcal CRBSI in clinical studies 5
  • Never use antibiotic lock therapy alone—it must be combined with systemic antibiotics 1

Monitoring and Follow-Up

  • Obtain repeat blood cultures 72 hours after initiating therapy to document clearance 3, 6
  • If blood cultures remain positive at 72 hours, this indicates treatment failure and mandates catheter removal 1, 3
  • Assess for clinical improvement (defervescence, resolution of hemodynamic instability) within 48-72 hours 1, 3
  • Consider surveillance blood cultures 1 week after completing therapy if the catheter was retained 3

Special Considerations for Hemodialysis Catheters

  • For hemodialysis patients with S. haemolyticus CRBSI, guidewire exchange is an acceptable alternative to immediate removal if symptoms resolve within 2-3 days and there is no metastatic infection 1
  • Use validated dosing schedules for vancomycin to ensure therapeutic concentrations in dialysis patients 1
  • Antibiotic lock solution can be renewed after each dialysis session 1

Common Pitfalls to Avoid

  • Do not treat with antibiotics alone without addressing the catheter—this leads to recurrence in the majority of cases 1
  • Do not delay catheter removal if bacteremia persists >72 hours, as this increases risk of metastatic complications and mortality 1
  • Do not assume all coagulase-negative staphylococci are equally virulent—while S. haemolyticus is generally less virulent than S. aureus, it can still cause serious complications if inadequately treated 4
  • Be aware of vancomycin resistance potential in S. haemolyticus, particularly with prolonged vancomycin exposure 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Duration of Meropenem for Catheter-Related Bloodstream Infections (CRBSI)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Coagulase-Negative Staphylococci Blood Culture Interpretation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Catheter-Related Bloodstream Infection (CRBSI) Caused by Burkholderia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.